📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK (2022)

First Author: Shields A

Attributed to: Gene Editing in X-Linked Agammaglobulinaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxac008

PubMed Identifier: 35641155

Publication URI: http://europepmc.org/abstract/MED/35641155

Type: Journal Article/Review

Parent Publication: Clinical and Experimental Immunology

Issue: 3

ISSN: 0009-9104